SCHEMBL10120340

SCHEMBL10120340

CC(c1nc2ccccn2c(=O)c1-c1ccccc1S)N1C(=O)c2ccccc2C1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.36
PKM P14618 3/20 0.35
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
THRB P10828 1/20 0.33
KCNA5 P22460 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ATM Q13315 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 2/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NTRK1 P04629 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
TP53 P04637 1/20 0.32
STAT3 P40763 1/20 0.32
STAT1 P42224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119947 0.77 PIK3CD (0.43) PIK3CDHSP90AA1HSP90AB1THRBSMN1; SMN2
SCHEMBL10119944 0.72 PIK3CD (0.34) PIK3CDPKMKCNA5SMN1; SMN2ATM
SCHEMBL10119986 0.71 HTT (0.37) PIK3CDPKMKCNA5SMN1; SMN2ATM
SCHEMBL10120334 0.69 PIK3CD (0.47) PIK3CD
SCHEMBL890545 0.68 KDM4E (0.44) PIK3CDHSP90AA1HSP90AB1THRBSMN1; SMN2
SCHEMBL890481 0.68 PIK3CD (0.54) PIK3CDHSP90AA1HSP90AB1SMN1; SMN2KDM4E
SCHEMBL4471060 0.67 MEN1 (0.51) PKMKCNA5SMN1; SMN2ATMKDM4E
SCHEMBL890589 0.66 HSP90AA1 (0.42) HSP90AA1HSP90AB1THRBSMN1; SMN2KDM4E
SCHEMBL23224181 0.66 RAB9A (0.41) PKMKCNA5SMN1; SMN2ATMKDM4E
SCHEMBL10119948 0.64 PIK3CD (0.80) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120083502-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083502-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES MCL1, MALT1, BCL9 PIK3CD 24/4885PKM 3204/4885HSP90AA1 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.